You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 7, July 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Sialadenosis in bulimia. A new treatment

P. S. Mehler and J. A. Wallace
Department of Internal Medicine, Columbine Hospital, Littleton, CO 80126.

OBJECTIVE--To see whether a cholinomimetic medication would help resolve the parotid gland enlargement associated with self-induced vomiting in bulimic patients. SETTING/DESIGN--The medication was administered on an inpatient eating disorder unit to bulimic patients with refractory sialadenosis. INTERVENTION--Pilocarpine hydrochloride drops were administered orally at a dosage of 1.25 to 5.0 mg/d until the parotid gland enlargement was significantly reduced. RESULTS--There was a marked diminution in the size of the parotid gland enlargement. CONCLUSION--Pilocarpine has proved to be beneficial in the treatment of sialadenosis in bulimic patients.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnosing bulimia nervosa with parotid gland swelling
MANDEL and ABAI
Journal of the American Dental Association 2004;135:613-616.
ABSTRACT | FULL TEXT  

Bulimia Nervosa
Mehler
NEJM 2003;349:875-881.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.